Table 3.
Non-covalent interactions of top ranked drugs with Mpro (PDB ID-6LU7) (Pose predicted by AutoDock Vina).
| Drug candidate | Binding affinity | Hydrogen bond (AA…ligand) | Hydrophobic interaction (AA…ligand) | Electrostatic interaction (AA…ligand) | Other |
|---|---|---|---|---|---|
| Raltegravir | −9.1 | HIS164(2.245) C-O…H-N | CYS145(5.309) Pi-Alkyl | ||
| LEU141(2.803) C-O…H-O | |||||
| SER144(2.123) N-H…O-C | |||||
| SER144(2.463) O-H…O-C | |||||
| CYS145(2.244) N-H…O-C | |||||
| HIS163(3.0656) C-H…O-H | |||||
| Simeprevir | −8.7 | ASN142(1.875) N-H…O-S | MET165(4.338) Alkyl | GLU166(3.950) Pi-Anion | |
| ASN142(2.648) C-O…H-C | GLN189(2.557) Pi-Sigma | ||||
| THR26(2.926) C-O…H-C | MET49(3.910) Alkyl | ||||
| GLU166(3.042) C-O…H-C | LEU27(5.136) Alkyl | ||||
| GLU166(2.902) Pi-Donor | MET165(4.224) Pi-Alkyl | ||||
| HIS41(4.325) Pi-Alkyl | |||||
| HIS41 (4.662) Pi-Alkyl | |||||
| Remdesivir | −7.8 | ASN142(2.202) C-O…H-N | MET49(4.617) Pi-Alkyl | MET165(5.618) Pi-Sulfur | |
| PHE140(2.838) C-O…H-O | |||||
| GLU166(2.456) C-O…H-O | |||||
| HIS163(2.246) C-N…H-O | |||||
| GLY143(2.102) N-H…O-C | |||||
| HIS163(2.637) C-N…H-C | |||||
| LEU141(2.640) C-H…N-C | |||||
| ASN142(3.051) C-H…O-C | |||||
| HIS172(3.021) C-H…O-H | |||||
| Cobicistat | −7.4 | GLN189(2.571) C-O…H-N | MET49 (4.863) Alkyl | MET165(5.563) Pi-Sulfur | |
| GLN189(2.288) C-O…H-N | CYS145(4.230) Pi-Alkyl | ||||
| ASN142(2.650) N-H…O-C | MET49(4.644) Pi-Alkyl | ||||
| SER144(2.948) O-H…O-C | |||||
| GLU166(2.803) C-O…H-C | |||||
| GLN189(2.691) C-O…H-C | |||||
| ASN142(2.434) C-O…H-C | |||||
| PHE140(2.693) C-O…H-C | |||||
| GLN189(2.345) C-O…H-C | |||||
| Daclatasvir | −7.2 | ASN142(2.319) C-O…H-N | LEU50(4.214) Alkyl | ||
| GLN189(2.677) C-O…H-N | LEU50(4.224) Alkyl | ||||
| SER144(2.537) O-H…O-C | CYS145(4.379) Alkyl | ||||
| HIS163(2.527) C-N…H-C | ALA191(4.919) Alkyl | ||||
| ASN142(2.437) C-O…H-C | ALA191(4.252) Pi-Alkyl | ||||
| HIS41(4.213) Pi-Alkyl |